Wall Street Journal, March 1, 2017
Peter Loftus


Read the Full Article

This article is behind a paywall. Harvard affiliates can access it via Hollis+.

Several major U.S. drug companies have squelched an investor campaign aimed at forcing companies to disclose more information about when and why they raise prices. [...]

health care finance pharmaceuticals regulation